Published online October 31, 2008
PEDIATRICS Vol. 122 No. 5 November 2008, pp. 1127-1134 (doi:10.1542/10.1542/peds.2008-2175)

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Related Collections Infectious Disease & Immunity Social Bookmarking                         What's this?

POLICY STATEMENT

HIV Testing and Prophylaxis to Prevent Mother-to-Child Transmission in the United States

Committee on Pediatric AIDS

Universal HIV testing of pregnant women in the United States is the key to prevention of mother-to-child transmission of HIV. Repeat testing in the third trimester and rapid HIV testing at labor and delivery are additional strategies to further reduce the rate of perinatal HIV transmission. Prevention of mother-to-child transmission of HIV is most effective when antiretroviral drugs are received by the mother during her pregnancy and continued through delivery and then administered to the infant after birth. Antiretroviral drugs are effective in reducing the risk of mother-to-child transmission of HIV even when prophylaxis is started for the infant soon after birth. New rapid testing methods allow identification of HIV-infected women or HIV-exposed infants in 20 to 60 minutes. The American Academy of Pediatrics recommends documented, routine HIV testing for all pregnant women in the United States after notifying the patient that testing will be performed, unless the patient declines HIV testing ("opt-out" consent or "right of refusal"). For women in labor with undocumented HIV-infection status during the current pregnancy, immediate maternal HIV testing with opt-out consent, using a rapid HIV antibody test, is recommended. Positive HIV antibody screening test results should be confirmed with immunofluorescent antibody or Western blot assay. For women with a positive rapid HIV antibody test result, antiretroviral prophylaxis should be administered promptly to the mother and newborn infant on the basis of the positive result of the rapid antibody test without waiting for results of confirmatory HIV testing. If the confirmatory test result is negative, then prophylaxis should be discontinued. For a newborn infant whose mother's HIV serostatus is unknown, the health care professional should perform rapid HIV antibody testing on the mother or on the newborn infant, with results reported to the health care professional no later than 12 hours after the infant's birth. If the rapid HIV antibody test result is positive, antiretroviral prophylaxis should be instituted as soon as possible after birth but certainly by 12 hours after delivery, pending completion of confirmatory HIV testing. The mother should be counseled not to breastfeed the infant. Assistance with immediate initiation of hand and pump expression to stimulate milk production should be offered to the mother, given the possibility that the confirmatory test result may be negative. If the confirmatory test result is negative, then prophylaxis should be stopped and breastfeeding may be initiated. If the confirmatory test result is positive, infants should receive antiretroviral prophylaxis for 6 weeks after birth, and the mother should not breastfeed the infant.

---

Key Words: human immunodeficiency virus • HIV • perinatal transmission • antiretroviral • prophylaxis • prevention • testing

Abbreviations: MTCT—mother-to-child transmission • AAP—American Academy of Pediatrics • ARV—antiretroviral • CDC—Centers for Disease Control and Prevention • EIA—enzyme immunoassay • IFA—immunofluorescent antibody • ZDV—zidovudine • ACOG—American College of Obstetricians and Gynecologists • USPHS—US Public Health Service

---

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

The following policy statements have been revised:

Technical Report: Perinatal Human Immunodeficiency Virus Testing and Prevention of Transmission

and
Pediatrics 106: 88e-88. [Full Text]

Perinatal Human Immunodeficiency Virus Testing

Pediatrics 95: 303-307.

This article has been cited by other articles:

				M. H. Rathore Diagnosis and Therapy of HIV-Infected Infants: Earlier Is Better AAP Grand Rounds, February 1, 2009; 21(2): 18 - 18. [Full Text] [PDF]

				P. L. Havens and L. M. Mofenson Routine Newborn HIV Testing: An Idea Whose Time Has Come: In Reply Pediatrics, February 1, 2009; 123(2): e363 - e364. [Full Text] [PDF]

				B. K. Alverson and N. Alexander Routine Newborn HIV Testing: An Idea Whose Time Has Come Pediatrics, February 1, 2009; 123(2): e362 - e363. [Full Text] [PDF]

				P. L. Havens, L. M. Mofenson, and and the Committee on Pediatric AIDS Evaluation and Management of the Infant Exposed to HIV-1 in the United States Pediatrics, January 1, 2009; 123(1): 175 - 187. [Abstract] [Full Text] [PDF]

				Human Immunodeficiency Virus Infection Red Book, January 1, 2009; 2009(1): 380a - 400a. [Full Text]

				L. O'Keefe Reducing mother-to-child transmission * Policy stresses importance of universal HIV testing of pregnant women AAP News, November 1, 2008; 29(11): 16 - 16. [Full Text] [PDF]